Ardelyx (ARDX) Assets (2013 - 2026)
Ardelyx's (ARDX) quarterly Assets came in at $504.5 million in Q1 2026, up 22.99% YoY from $410.2 million in Q1 2025, and up 0.58% on a QoQ basis from $501.6 million in Q4 2025.
Ardelyx (ARDX) Assets (2013 - 2026) Analysis & Trends
Ardelyx (ARDX) has 14 years of Assets data on file, last reported at $504.5 million in Q1 2026.
- Quarterly Assets rose 22.99% year-over-year to $504.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $504.5 million (up 22.99% YoY) and the FY2025 annual result came in at $501.6 million, up 15.11% from the prior year.
- Assets grew to $504.5 million in Q1 2026, from $501.6 million in the prior quarter.
- In the past five years, Assets ranged from a high of $504.5 million in Q1 2026 to a low of $129.4 million in Q1 2022.
- A 5-year average of $321.7 million and a median of $342.4 million in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets tumbled 38.46% — and 2023, when it soared 100.02%.
- Tracing ARDX's Assets over 5 years: stood at $190.1 million in 2022, then soared by 56.57% to $297.6 million in 2023, then soared by 46.43% to $435.8 million in 2024, then advanced by 15.11% to $501.6 million in 2025, then increased by 0.58% to $504.5 million in 2026.
- The last three Assets figures came in at $504.5 million (Q1 2026), $501.6 million (Q4 2025), and $486.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Ardelyx | 1.01 Bn | 729.71 Mn | 115.12 Mn | 575.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 575.89 Mn |
| Mar 31, 2026 | 504.51 Mn |
| Dec 31, 2025 | 501.60 Mn |
| Sep 30, 2025 | 486.17 Mn |
| Jun 30, 2025 | 466.77 Mn |
| Mar 31, 2025 | 410.19 Mn |
| Dec 31, 2024 | 435.75 Mn |
| Sep 30, 2024 | 367.86 Mn |
| Jun 30, 2024 | 343.49 Mn |
| Mar 31, 2024 | 342.38 Mn |
| Dec 31, 2023 | 297.58 Mn |
| Sep 30, 2023 | 289.38 Mn |
| Jun 30, 2023 | 211.20 Mn |
| Mar 31, 2023 | 217.02 Mn |
| Dec 31, 2022 | 190.07 Mn |
| Sep 30, 2022 | 144.67 Mn |
| Jun 30, 2022 | 131.61 Mn |
| Mar 31, 2022 | 129.41 Mn |
| Dec 31, 2021 | 149.91 Mn |
| Sep 30, 2021 | 170.85 Mn |